Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard T Moxley

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Journal of Neurology|October 27, 2004
Myotonic dystrophy type 2 and related myotonic disordersGiovanni Meola, Richard T Moxley
Current Treatment Options in Neurology|March 13, 2008
Treatment options for Duchenne muscular dystrophyEmma Ciafaloni, Richard T Moxley
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 31, 2007
The nondystrophic myotoniasChad R Heatwole, Richard T Moxley
Neurology|February 3, 2016
Practice guideline update summary: Corticosteroid treatment of Duchenne muscular dystrophy [RETIRED]: Report of the Guideline Development Subcommittee of the American Academy of NeurologyDavid Gloss, Richard T Moxley, Stephen Ashwal, et al.
Neuromuscular Disorders : NMD|August 29, 2009
Scaled-down genetic analysis of myotonic dystrophy type 1 and type 2Masayuki Nakamori, Krzysztof Sobczak, Richard T Moxley, et al.
Archives of Neurology|August 16, 2006
Laboratory abnormalities in ambulatory patients with myotonic dystrophy type 1Chad R Heatwole, Jill Miller, Bill Martens, et al.
Journal of Child Neurology|June 29, 2010
Change in natural history of Duchenne muscular dystrophy with long-term corticosteroid treatment: implications for managementRichard T Moxley, Shree Pandya, Emma Ciafaloni, et al.
Muscle & Nerve|June 26, 2007
Computerized hand grip myometry reliably measures myotonia and muscle strength in myotonic dystrophy (DM1)Richard T Moxley, Eric L Logigian, William B Martens, et al.
Human Molecular Genetics|October 22, 2004
Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neuronsHong Jiang, Ami Mankodi, Maurice S Swanson, et al.
Journal of the American Academy of Dermatology|July 26, 2002
Thalidomide therapy for cicatricial pemphigoidDaihung Jay Duong, Richard T Moxley, Robert M Kellman, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Journal of Neurology|October 27, 2004
Myotonic dystrophy type 2 and related myotonic disordersGiovanni Meola, Richard T Moxley
Current Treatment Options in Neurology|March 13, 2008
Treatment options for Duchenne muscular dystrophyEmma Ciafaloni, Richard T Moxley
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 31, 2007
The nondystrophic myotoniasChad R Heatwole, Richard T Moxley
Neurology|February 3, 2016
Practice guideline update summary: Corticosteroid treatment of Duchenne muscular dystrophy [RETIRED]: Report of the Guideline Development Subcommittee of the American Academy of NeurologyDavid Gloss, Richard T Moxley, Stephen Ashwal, et al.
Neuromuscular Disorders : NMD|August 29, 2009
Scaled-down genetic analysis of myotonic dystrophy type 1 and type 2Masayuki Nakamori, Krzysztof Sobczak, Richard T Moxley, et al.
Archives of Neurology|August 16, 2006
Laboratory abnormalities in ambulatory patients with myotonic dystrophy type 1Chad R Heatwole, Jill Miller, Bill Martens, et al.
Journal of Child Neurology|June 29, 2010
Change in natural history of Duchenne muscular dystrophy with long-term corticosteroid treatment: implications for managementRichard T Moxley, Shree Pandya, Emma Ciafaloni, et al.
Muscle & Nerve|June 26, 2007
Computerized hand grip myometry reliably measures myotonia and muscle strength in myotonic dystrophy (DM1)Richard T Moxley, Eric L Logigian, William B Martens, et al.
Human Molecular Genetics|October 22, 2004
Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neuronsHong Jiang, Ami Mankodi, Maurice S Swanson, et al.
Journal of the American Academy of Dermatology|July 26, 2002
Thalidomide therapy for cicatricial pemphigoidDaihung Jay Duong, Richard T Moxley, Robert M Kellman, et al.
Pageof 5